Table 2.
AKI, sCr changes, and intravenous contrast volume applied according to time to admission glucose
| Variables | Acute hyperglycemia |
p | ||
|---|---|---|---|---|
| no (n = 663) | mild (n = 320) | severe (n = 82) | ||
| AKI, n (%) | 49 (7) | 25 (8) | 16 (20) | <0.001 |
| Admission eGFR, ml/min/1.73 m2 | 74 ± 18 | 68 ± 17 | 68 ± 17 | <0.001 |
| Admission sCr, mg/dl | 1.11 ± 0.22 | 1.19 ± 0.31 | 1.21 ± 0.31 | <0.001 |
| Peak sCr, mg/dl | 1.13 ± 0.34 | 1.21 ± 0.53 | 1.36 ± 0.67 | <0.001 |
| sCr change in hospital, mg/dl | 0.09 ± 0.25 | 0.07 ± 0.34 | 0.17 ± 0.48 | 0.04 |
| sCr at discharge, mg/dl | 1.09 ± 0.26 | 1.16 ± 0.36 | 1.21 ± 0.50 | 0.01 |
| Amount of contrast materials1 ml | 147 ± 43 | 141 ± 51 | 137 ± 58 | 0.541 |
Values are means ± SD unless otherwise indicated.
a
Information on the amount of contrast volume was available for 327 patients.